SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 26, 2004
ROCKWELL MEDICAL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its Charter)
Michigan 000-230-661 38-3317208
---------------------------- ----------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
30142 Wixom Road, Wixom Michigan 48393
---------------------------------------- -------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (248) 960-9009
Not applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 9. Regulation FD Disclosure.
On February 26, 2004, the Company issued the press release attached hereto
as Exhibit 99.1, announcing its financial results for the year and quarter ended
December 31, 2003.
Item 12. Results of Operations and Financial Condition.
On February 26, 2004, the Company issued the press release attached hereto
as Exhibit 99.1, announcing its financial results for the year and quarter ended
December 31, 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROCKWELL MEDICAL TECHNOLOGIES, INC.
Date: March 1, 2004 By: /s/ Thomas E. Klema
-----------------------------------
Thomas E. Klema
Its: Chief Financial Officer